Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0499 | ||||
Gene Name | SLCO1C1 | ||||
Protein Name | Organic anion transporting polypeptide 1C1 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | OAT-RP-5; OATP-14; OATP-F; OATP14; OATP1C1; OATPF; OATPRP5; Organic anion transporter F; Organic anion transporter polypeptide-related protein 5; Organic anion-transporting polypeptide 14; SLC21A14; SLCO1C1; Solute carrier family 21 member 14; Solute carrier organic anion transporter family member 1C1; Thyroxine transporter | ||||
DT Family | Organo Anion Transporter (OAT) Family ; | ||||
Tissue Specificity | Highly expressed in brain and in Leydig cellsin testis. Detected in many brain regions with the exception ofpons and cerebellum. Not strongly enriched in cerebralmicrovessels. | ||||
Function | This Na(+)-independent transporter mediates the organic anions such as the thyroid hormones thyroxine (T4) and rT3 and may play a signifiant role in regulating T4 flux into and out of the brain. Other potential substrates, such as triiodothyronine (T3), 17-beta-glucuronosyl estradiol, estrone-3-sulfate and sulfobromophthalein (BSP) are transported with much lower efficiency. | ||||
Disease(s) | Medical abortion [ICD-11: JA00.1] | ||||
Endogenous Substrate(s) | Organoanions; Thyroid hormones | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(α) Genetic Polymorphisms of This DT |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 3 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Dinoprostone
|
Approved | Drug Info | Medical abortion | JA00.1 | [1] |
Levothyroxine
|
Approved | Drug Info | Hypothyroidism | 5A00.2 | [1] |
Liothyronine
|
Approved | Drug Info | Hypothyroidism | 5A00.2 | [2] |
Drug-DT Affinity Assessed by Cell Line |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
Levothyroxine | Approved | Drug Info | Chinese hamster ovary (CHO) cells-OATP1C1 | Km = 0.0904 microM | [1] |
References | |||||
1 | Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Mol Endocrinol. 2002 Oct;16(10):2283-96. | ||||
2 | Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology. 2004 Sep;145(9):4384-91. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.